Name:  ___                 Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___: ___ has class III morbid obesity with 
weight of 235.8
pounds as of ___ with her initial screen weight of 232.1 
pounds as of ___, height of 62.25 inches and BMI of 42.8. 
Her previous weight loss efforts have included Weight Watchers, 
___ diet, Slim-Fast, ___ visits losing 
up to 15 pounds but her weight loss attempts at failed to 
produce significant and/or laxative results.  She has not taken 
prescription weight loss medications or used over-the-counter 
ephedra-containing appetite suppressants/herbal supplements.  
She stated that her lowest adult weight was 150-160 pounds at 
the age of ___ and her highest weight is her weight of 238 
pounds as of ___.  She weighed 174 pounds in ___, 191 
pounds in ___, and 210 pounds one year ago.  She stated that 
she has been struggling with weight since childhood and more 
significantly over the past couple of years.  Factors 
contributing to her excess weight include large portions, 
late-night eating, and grazing, convenience eating, boredom and 
lack of exercise.  She denied history of eating disorders - no 
anorexia, bulimia, diuretic or laxative abuse and she denied 
binge eating.  She does not have a diagnosis of depression 
except for anxiety with panic attacks and she has not been 
followed by a therapist nor has she been hospitalized for mental 
health issues and she is on psychotropic medications 
(sertraline).

 
Past Medical History:
1)  obstructive sleep apnea fitted for CPAP
2)  hypothyroidism
3)  asthma on inhaler with no recent flares or prednisone taper
4)  pre-diabetes (hemoglobin A1c of 5.9%, elevated fasting 
    glucose of 135)
5)  history of gestational diabetes
6)  sickle cell trait
7)  vitamin B12 deficiency
8)  chronic idiopathic urticarial
9)  history of hydradenitis
10) hyperlipidemia with elevated triglycerides
11) vitamin D deficiency
12) chest wall tenderness
13) history of breast nodule by CTA left breast-bx - 
fibroadenoma

Her surgical history is noted for:

1)  breast biopsy consistent with fibroadenoma ___
2)  s/p c-section x 2 in ___ and ___
3)  cyst removal bilateral axilla ___
4)  breast reduction ___.

 
Social History:
___
Family History:
Her family history is noted for father deceased with history of 
diabetes, HIV infection; mother living with history of MI and 
hypertension; maternal grandfather with history of diabetes; 
paternal grandmother with diabetes; no family history of breast, 
ovarian, uterus or colon CA. 
 
Physical Exam:
VS: 98.7, 84, 122/86, 18, 94RA
Constitutional: no acute distress
Neuro: alert and oriented x 3
Cardiac: regular rate and rhythm, no murmurs appreciated
Resp: clear to auscultation, bilaterally
Abdomen: soft, appropriate ___ tenderness without 
rebound tenderness or guarding
Wounds: abdominal lap sites with steri-strips, CDI
Ext: no lower extremity edema
 
Pertinent Results:
LABS:
___ 09:28AM BLOOD Hct-35.4#
___ 05:35AM BLOOD Hct-26.9*
___ 01:59PM BLOOD Hct-34.9

IMAGING:
UGI SGL CONTRAST W/ KUB: 
No evidence of leak or obstruction.
 
Brief Hospital Course:
The patient presented to pre-op on ___. Pt was 
evaluated by anaesthesia and taken to the operating room for 
laparoscopic sleeve gastrectomy. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation. 

Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA and then 
transitioned to oral oxycodone once tolerating a stage 2 diet. 
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization. 
GI/GU/FEN: The patient was initially kept NPO.  A methylene blue 
dye test (intra-operative) and  an upper GI study (POD1) were 
both negative for a leak, therefore, the diet was advanced 
sequentially to a Bariatric Stage 3 diet, which was well 
tolerated. Patient's intake and output were closely monitored.  
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.
HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.
Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.

At the time of discharge, the patient was doing well, afebrile 
with stable vital signs.  The patient was tolerating a stage 3 
diet, ambulating, voiding without assistance, and pain was well 
controlled.  The patient received discharge teaching and 
follow-up instructions with understanding verbalized and 
agreement with the discharge plan.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Albuterol Inhaler ___ PUFF IH Q4H:PRN Cough or wheezing 
2. Clindamycin 1% Solution 1 Appl TP BID 
3. Cyanocobalamin 1000 mcg PO DAILY 
4. Levonorgestrel Dose is Unknown  PO ONCE 
5. Levothyroxine Sodium 125 mcg PO DAILY 
6. Sertraline 25 mg PO DAILY 
7. Vitamin D ___ UNIT PO DAILY 

 
Discharge Medications:
1.  Acetaminophen (Liquid) 650 mg PO Q6H:PRN Pain - Moderate  
2.  OxycoDONE Liquid ___ mg PO Q4H:PRN Pain - Moderate 
RX *oxycodone 5 mg/5 mL 5 mg by mouth every four (4) hours 
Refills:*0 
3.  Ranitidine (Liquid) 150 mg PO BID 
RX *ranitidine HCl 15 mg/mL 10 ml by mouth twice a day 
Refills:*0 
4.  Levonorgestrel unknown  PO ASDIR Duration: 1 Dose  
5.  Albuterol Inhaler ___ PUFF IH Q4H:PRN Cough or wheezing  
6.  Clindamycin 1% Solution 1 Appl TP BID  
7.  Cyanocobalamin 1000 mcg PO DAILY  
8.  Levothyroxine Sodium 125 mcg PO DAILY  
9.  Sertraline 25 mg PO DAILY  
10.  Vitamin D ___ UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Discharge Instructions: Please call your surgeon or return to 
the emergency department if you develop a fever greater than 
101.5, chest pain, shortness of breath, severe abdominal pain, 
pain unrelieved by your pain medication, severe nausea or 
vomiting, severe abdominal bloating, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness 
or swelling around your incisions, or any other symptoms which 
are concerning to you.

Diet: Stay on Stage III diet until your follow up appointment. 
Do not self advance
diet, do not drink out of a straw or chew gum.

Medication Instructions:
Resume your home medications, CRUSH ALL PILLS.
You will be starting some new medications:
1.  You are being discharged on medications to treat the pain 
from your operation. These medications will make you drowsy and 
impair your ability to drive a motor vehicle or operate 
machinery safely. You MUST refrain from such activities while 
taking these medications.
2. You should begin taking a chewable complete multivitamin with 
minerals. No gummy vitamins.
3. You will be taking Zantac liquid ___ mg twice daily for one 
month. This medicine prevents gastric reflux.
4. You will be taking Actigall 300 mg twice daily for 6 months. 
This medicine prevents you from having problems with your 
gallbladder.
5. You should take a stool softener, Colace, twice daily for 
constipation as needed, or until you resume a normal bowel 
pattern.
6. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and 
Naproxen. These agents will cause bleeding and ulcers in your 
digestive system.

Activity:
No heavy lifting of items ___ pounds for 6 weeks. You may 
resume moderate
exercise at your discretion, no abdominal exercises.

Wound Care:
You may shower, no tub baths or swimming. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Your steri-strips will fall off on their own. Please remove any 
remaining strips ___ days after surgery.
Please call the doctor if you have increased pain, swelling, 
redness, or drainage from the incision sites. 

 
Followup Instructions:
___